Reliable Diagnostics for Professionals
Contact usReagena is a Finnish, diagnostics growth company with product development and manufacturing facility in Kuopio region. Reagena’s mission is to be partner of choice in providing solutions and services that optimize patient care pathways while reducing the burden on healthcare.
Explore Our Zoonotic Solutions
Reagena is an undisputed leader in Hantavirus rapid diagnostics. Reagena offers rapid tests intended for qualitative detection for Puumala virus and Dobrava or Hantaan virus specific IgM antibodies from human serum or plasma. Test results are used as an aid in the diagnosis of acute Hantavirus infections.


Reagena is a pioneer in rapid diagnostics for zoonotic diseases and lately focused on the diagnostic tests for Lyme Borreliosis, Lyme neuroborreliosis and Tick-borne encephalitis. These tests are intended for use as an aid for diagnosis of Lyme Disease and Tick-borne encephalitis.
News

Meet us at ESCMID 2025 at Vienna
Reagena is participating in ESCMID (Congress of the European Society of Clinical Microbiology and Infectious Diseases) taking place in Vienna, on…

Kinetics of tick-borne encephalitis virus IgM antibody responses in serum and cerebrospinal fluid
We are excited to share that a recent publication has highlighted our ReaScan TBE IgM rapid test as a pivotal tool for tick-borne encephalitis…

TICK SEASON 2024 CAMPAIGN – WE HAVE A WINNER…
Reagena announced a sales campaign of Reagena’s products for tick-transmitted diseases. Reagena’s distributors with Best sales growth for…

Development of new ReaScan Mobile tests
Duration12/2023 – 12/2025 Total Budget498 520 € EU funding228 960 € Our company has received funding from the European…